0001562180-17-001448.txt : 20170404
0001562180-17-001448.hdr.sgml : 20170404
20170404182047
ACCESSION NUMBER: 0001562180-17-001448
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20170331
FILED AS OF DATE: 20170404
DATE AS OF CHANGE: 20170404
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIO-TECHNE Corp
CENTRAL INDEX KEY: 0000842023
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 411427402
STATE OF INCORPORATION: MN
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 614 MCKINLEY PL N E
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
BUSINESS PHONE: 6123798854
MAIL ADDRESS:
STREET 1: 614 MCKINLEY PLACE NE
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNE CORP /MN/
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hippel James
CENTRAL INDEX KEY: 0001603594
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-17272
FILM NUMBER: 17740194
MAIL ADDRESS:
STREET 1: 614 MCKINLEY PLACE NE
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2017-03-31
false
0000842023
BIO-TECHNE Corp
TECH
0001603594
Hippel James
614 MCKINLEY PLACE N.E.
MINNEAPOLIS
MN
55413
false
true
false
false
Chief Financial Officer
Common Stock
2017-03-31
4
F
false
800.00
101.65
D
3079.00
D
Restricted Stock Unit
Common Stock
4925.00
4925.00
D
Restricted Stock Unit
Common Stock
3000.00
3000.00
D
Stock Option (Right to Buy)
108.49
2022-08-07
Common Stock
18750.00
18750.00
D
Stock Option (Right to Buy)
106.59
2023-08-18
Common Stock
30400.00
30400.00
D
Stock Option (Right to Buy)
94.35
2021-08-12
Common Stock
35000.00
35000.00
D
Stock Option (Right to Buy)
86.25
2021-04-01
Common Stock
10000.00
10000.00
D
Stock Options (Right to buy)
108.49
2022-08-07
Common Stock
25000.00
25000.00
D
Stock Options (Right to buy)
106.59
2023-08-18
Common Stock
40533.00
40533.00
D
Stock Options (Right to buy)
86.25
2021-04-01
Common Stock
25000.00
25000.00
D
The reporting person has elected to satisfy his withholding obligation in connection with the vesting of a prior restricted stock unit grant by directing the Company to withhold shares otherwise issuable pursuant to the previously reported grant.
6,250 shares vest on each of 4/1/15, 4/1/16, 4/1/17 and 4/1/18.
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock.
Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)
Vests in full or in part on 8/7/18 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)
Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
8,750 shares vest on each of 8/12/15, 8/12/16, 8/12/17 and 8/12/18.
Vests in full or in part if certain performance goals are achieved.
6,250 shares vest on each of 8/7/16, 8/7/17, 8/7/18 and 8/7/19.
Vests 10,134 shares on 8/18/17, and 10,133 shares on each of 8/18/18, 8/18/19 and 8/18/20.
/s/ Brenda S. Furlow, attorney in fact for James Hippel pursuant to Power of Attorney filed herewith
2017-04-04
EX-24
2
poahippel.txt
JAMESHIPPELPOA
POWER OF ATTORNEY The undersigned hereby constitutes and appoints Brenda S.
Furlow, James Hippel, Melodie R. Rose and Elizabeth M. Dunshee, or either of
them acting alone, the undersigned's true and lawful attorneys-in-fact and
agent with full power of substitution and resubstitution, for the undersigned
and in the undersigned's name, place and stead, in any and all capacities, to
sign any or all Forms 3, Forms 4 and Forms 5 relating to beneficial ownership
of securities of Techne Corporation (the "Issuer"), to file the same, with
all exhibits thereto and other documents in connection therewith, with the
Securities and Exchange Commission and to deliver a copy of the same to the
Issuer, granting unto said attorney-in-fact and agent full power and authority
to do and perform each and every act and thing requisite and necessary to be
done in and about the premises, as fully to all intents and purposes as the
undersigned might or could do in person, hereby ratifying and confirming
all said attorneys-in-fact and agent, or his substitute or substitutes, may
lawfully do or cause to be done by virtue thereof. The undersigned acknowledges
that the foregoing attorney-in-fact, in serving in such capacity at the
request of the undersigned, is not assuming any of the undersigned's
responsibilities to comply with Section 16 of the Securities Exchange Act of
1934. This Power of Attorney shall remain in effect until such time as the
undersigned is no longer subject to the provisions of Section 16 of the
Securities Exchange Act of 1934 with respect to securities of the Issuer.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 30 day of October, 2014.
/s/ James Hippel